An Efficacy and Safety Study of DFN-02

Trial Profile

An Efficacy and Safety Study of DFN-02

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Oct 2017

At a glance

  • Drugs DFN 02 (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Sponsors Dr Reddys Laboratories
  • Most Recent Events

    • 09 Oct 2017 Status changed from active, no longer recruiting to completed.
    • 11 Sep 2017 According to The International Headache Society media release, results from this trial presented at the 18th Congress of the International Headache Society.
    • 07 Sep 2017 According to a Promius Pharma media release, results from this trial will be presented at the 18th Congress of the International Headache Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top